Drugs / Allogeneic donor plasma
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05404932 | Dec 2022 → Sep 2024 | hypoplasminogenemia | University of Saskatchewan | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic donor plasma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05404932 ↗ |
| Action | Restore | “Plasminogen replacement (in the form of topical drops of plasminogen concentrate or allogenic plasma)” NCT05404932 ↗ |
| Route | Other | “using aliquoted allogenic plasma provided by Canadian Blood Services for intra-ocular application” NCT05404932 ↗ |